Equities

Ami Organics Ltd

AMIORG:NSI

Ami Organics Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,250.00
  • Today's Change-0.50 / -0.04%
  • Shares traded20.72k
  • 1 Year change+6.84%
  • Beta--
Data delayed at least 15 minutes, as of May 18 2024 07:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Ami Organics Limited is an India-based manufacturer of specialty chemicals with varied end usage, focus on the development and manufacturing of pharma intermediates for regulated and generic active pharmaceutical ingredient (APIs) and new chemical entity (NCEs). It manufactures pharma intermediates for certain APIs, including dolutegravir, trazodone, entacapone, nintedanib and rivaroxaban. The pharma intermediates, which the Company manufactures have application in certain high-growth therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant. It has developed and commercialized over 450 pharma intermediates for APIs and NCEs across 17 therapeutic areas. Its specialty chemicals have applications in the agrochemicals and fine chemicals industries. The Company supplies its products to more than 150 customers directly in India and to approximately 25 countries overseas.

  • Revenue in INR (TTM)7.17bn
  • Net income in INR427.73m
  • Incorporated2007
  • Employees602.00
  • Location
    Ami Organics LtdPlot No. 440/4, 5 & 6,, Road No. 82/A,SURAT 394230IndiaIND
  • Phone+91 7 573015366
  • Fax+91 261 757301536
  • Websitehttps://www.amiorganics.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sharda Cropchem Ltd31.63bn318.83m37.25bn182.00119.551.6612.461.183.453.45349.50247.960.75412.201.90--0.76076.801.3211.6825.9428.031.017.361.232.430.008119.39-21.819.59-90.68-28.9713.72-5.59
Neogen Chemicals Ltd6.91bn356.60m38.29bn581.00104.265.0465.425.5413.9213.92270.64288.190.54921.133.01--2.845.354.528.3444.6232.995.167.590.76142.080.349715.520.654423.64-28.6611.1371.955.92
Rossari Biotech Ltd18.31bn1.31bn38.63bn500.0029.603.6920.222.1123.6223.62330.69189.651.255.494.70--8.8910.5312.0614.3429.3429.847.147.661.329.860.10182.2610.5528.8121.8523.3924.44--
Fineotex Chemical Ltd5.54bn1.16bn39.89bn103.0034.51--32.737.2110.4410.4450.02--------53,751,720.00--17.65--21.9038.3335.2121.0515.49--136.92--8.2540.4029.3260.0731.2346.9631.95
Bharat Rasayan Ltd10.41bn586.50m40.52bn797.0069.09--47.923.89141.16141.162,505.13--------13,060,150.00--17.10--22.8828.4728.495.6312.57--28.84--0.4305-5.138.78-29.194.85-10.500.00
Nocil Ltd14.81bn1.20bn43.59bn675.0036.51--25.182.947.167.1688.59--------21,939,110.00--9.20--10.4343.1436.298.0912.15--99.39--38.642.8810.32-15.31-2.57-8.973.71
Privi Speciality Chemicals Ltd17.52bn949.07m44.58bn725.0046.724.8220.372.5424.4324.43447.68236.640.74031.575.45--4.035.097.038.5334.5030.725.456.480.53842.060.51726.148.985.49327.230.1404-2.31-4.36
AMI Organics Ltd7.17bn427.73m46.12bn602.0095.396.8471.536.4313.1113.11199.16182.750.77032.983.29--5.2310.476.9314.4742.6245.446.7911.761.1918.930.240911.7816.3325.14-48.6512.9267.37--
GHCL Ltd34.43bn7.94bn47.92bn3.84k6.011.615.351.3983.2683.26361.06311.150.77352.7817.29--17.8314.1819.6617.1842.6139.4323.0618.662.7328.150.065914.59-24.180.622-28.8517.76-17.7419.14
National Fertilizers Limited245.60bn-2.94bn49.92bn2.99k----76.440.2033-5.99-5.99501.09--------82,139,260.00--1.25--2.869.4816.40-1.200.884---2.37----86.7727.03582.4016.59-9.37--
Sudarshan Chemical Industries Ltd24.66bn3.32bn50.91bn1.03k15.44--10.882.0647.6347.63350.86--------24,032,330.00--6.44--11.5444.0233.5613.466.14--2.88--25.424.5911.23-65.55-10.2617.13-15.59
Epigral Ltd19.29bn1.96bn52.95bn936.0027.044.2216.572.7447.1347.13464.18301.830.73824.9111.18--7.50--10.31--39.53--10.15--0.30654.870.4346---11.84---44.57------
Rallis India Ltd26.48bn1.48bn53.98bn1.72k36.192.9520.602.047.677.67136.6194.050.9131.974.91--5.106.157.809.7040.4532.575.596.330.954810.940.067832.11-10.755.9460.97-0.969112.000.00
Paradeep Phosphates Ltd115.75bn999.10m56.42bn1.48k56.301.5818.170.48751.231.23141.6543.751.144.423.61--0.98353.422.308.6622.2620.390.86312.890.75131.200.5297---13.2321.58-67.16-8.8726.66--
Data as of May 18 2024. Currency figures normalised to Ami Organics Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

15.04%Per cent of shares held by top holders
HolderShares% Held
Plutus Wealth Management LLPas of 30 Jun 20233.00m8.13%
Norges Bank Investment Managementas of 30 Jun 20231.09m2.96%
UTI Asset Management Co. Ltd. (Investment Management)as of 30 Apr 2024427.45k1.16%
Tata Asset Management Ltd.as of 30 Apr 2024383.10k1.04%
Union Asset Management Co. Pvt Ltd.as of 30 Apr 2024231.30k0.63%
ITI Asset Management Ltd. (India)as of 30 Apr 2024136.35k0.37%
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 30 Apr 2024111.38k0.30%
Edelweiss Asset Management Ltd.as of 30 Apr 202470.00k0.19%
Bank of India Investment Managers Pvt Ltd.as of 30 Apr 202456.92k0.15%
BlackRock Fund Advisorsas of 09 May 202439.84k0.11%
More ▼
Data from 31 Dec 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.